Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Isa0984
    Member
    • Aug 2014
    • 15

    #16
    So it is the amount of operations (substitution, insertion, delition) that I have to do, to change my 50bp read to my reference. But why do I have then reads mapped to my reference with partly more than 10 mismatches?

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #17
      You'd have to go through the exact command that the company used and compare that to how things are processed inside bwa (by looking at the code rather than the documentation).

      Comment

      • Isa0984
        Member
        • Aug 2014
        • 15

        #18
        That means other options in BWA can change the maximum of my 3 "mismatches" and allow more... wow that makes it even more complecated for me. They said they used default parameters with the only change in the options mentioned above.

        Comment

        • GenoMax
          Senior Member
          • Feb 2008
          • 7142

          #19
          You are not able to get the raw data and recreate the result yourself? You could be spinning your wheels for a long while trying to find an explanation for their results.

          Note: Reading the beginning of the thread seems to indicate you have the raw data but are your results not matching the alignments the company did?
          Last edited by GenoMax; 03-19-2015, 06:26 AM.

          Comment

          • Isa0984
            Member
            • Aug 2014
            • 15

            #20
            I have the raw data, but I am not working at the institut anymore... and at home with my old little labtop, not really. Iam writing my thesis and there you look sometime at things deeper, then you should have done it before. But maybe I should simply take it like it is. Its just the urge to understand it in detail. Thanks a lot for your patience!

            Comment

            • GenoMax
              Senior Member
              • Feb 2008
              • 7142

              #21
              I see the dilemma now. You could use the results provided by the company as is but then you may not be able to defend them if questioned during your defense.

              Do you think the conclusion is going to differ if you were to do the analysis again? If you are sure the answer is no then you will have to make a decision.

              Comment

              • dpryan
                Devon Ryan
                • Jul 2011
                • 3478

                #22
                Neugier ist der Katze Tod, or perhaps "Curiosity killed the PhD thesis" would be a better variant

                But anyway, I agree with GenoMax. If their results look problematic at all then it's worthwhile to repeat the alignment simply so you know exactly how things were processed.

                Comment

                • Isa0984
                  Member
                  • Aug 2014
                  • 15

                  #23
                  Thats the point, but hopefully they will not ask... The good thing is, even Iam not so deep to this whole RNA-seq thing, Iam deeper then the others... so I just need a good explanation which they swollow.

                  Doing it again is no option. The only option I have is to terrorize the company, but customers service is not their strength and they explain me everytime that its too long ago, they are not able to look to the data... Which is incomprehensible for me.

                  Comment

                  • Isa0984
                    Member
                    • Aug 2014
                    • 15

                    #24
                    Good statement, I still need something creative for my "plain site"... Until now my favourite is "Die Zeit promoviert jeden"

                    Comment

                    • dpryan
                      Devon Ryan
                      • Jul 2011
                      • 3478

                      #25
                      This is RNAseq data that they aligned with bwa aln? I must have missed the RNAseq part earlier. I'm not sure how well bwa aln will deal with splicing...

                      BTW, I'm going to have to steal your saying

                      Comment

                      • Isa0984
                        Member
                        • Aug 2014
                        • 15

                        #26
                        Yes it is, but it was aligned to a transcriptome (apple by the way, its not the best, but better then nothing).
                        Thats fine, do it... it did it too and I really love it.

                        Comment

                        • dpryan
                          Devon Ryan
                          • Jul 2011
                          • 3478

                          #27
                          Ah, aligned to the transcriptome makes MUCH more sense! Your committee can't complain about that.

                          Comment

                          • Isa0984
                            Member
                            • Aug 2014
                            • 15

                            #28
                            At least something positive

                            Comment

                            Latest Articles

                            Collapse

                            • SEQadmin2
                              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                              by SEQadmin2



                              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                              ...
                              10-14-2026, 09:55 AM
                            • SEQadmin2
                              New Genomics Technologies Take Aim at Long-Standing Limits
                              by SEQadmin2


                              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                              ...
                              09-28-2026, 10:25 AM

                            ad_right_rmr

                            Collapse

                            News

                            Collapse

                            Topics Statistics Last Post
                            Started by SEQadmin2, 10-22-2026, 11:13 AM
                            0 responses
                            29 views
                            0 reactions
                            Last Post SEQadmin2  
                            Started by SEQadmin2, 10-22-2026, 10:48 AM
                            0 responses
                            22 views
                            0 reactions
                            Last Post SEQadmin2  
                            Started by SEQadmin2, 10-15-2026, 10:52 AM
                            0 responses
                            39 views
                            0 reactions
                            Last Post SEQadmin2  
                            Started by SEQadmin2, 10-14-2026, 05:39 AM
                            0 responses
                            45 views
                            0 reactions
                            Last Post SEQadmin2  
                            Working...